share_log

BRIEF-Alpha Cognition Inc - On Track And Plans To Release Data From Alpha-1062 Pivotal Trial During Q2 Of 2022

reuters ·  May 31, 2022 20:35

May 31 (Reuters) - Alpha Cognition Inc ACOG.V :

* ALPHA COGNITION INC - ON TRACK AND PLANS TO RELEASE DATA FROM ALPHA-1062 PIVOTAL TRIAL DURING Q2 OF 2022

* ALPHA COGNITION INC - PLANS TO MEET WITH FDA FOR ALPHA-1062 INTRANASAL FOR MTBI DURING Q3 OF 2022

* ALPHA COGNITION INC - Q1 2022 NET LOSS WAS $2.7 MILLION, OR A NET LOSS OF $0.04 PER SHARE

* ALPHA COGNITION INC - CASH, CASH EQUIVALENTS AS OF MARCH 31, 2022, WERE $9.1 MILLION

Source text for Eikon: ID:nBw2kCFj7a Further company coverage: ACOG.V

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment